BioSpace News Archive

University of Maryland School of Medicine Dean E. Albert Reece, MD, PhD, MBA announced that Peter B. Crino, MD, PhD, Professor and Chair of UMSOM’s Department of Neurology, has received the Javits Neuroscience Investigator Award, which provides $2.7 million in total funding.

Karyopharm Therapeutics Inc. today announced dosing of the first patient in the Phase 2 expansion of an ongoing open-label Phase 1/2 study investigating eltanexor, a novel oral, Selective Inhibitor of Nuclear Export (SINE) compound

Obsidian Therapeutics, Inc. today announced the appointment of Maria Fardis , Ph.D., to its Board of Directors.

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) , will hold a conference call and webcast to discuss its third quarter 2021 operating results Friday, November 5, 2021 at 8:30 a.m. EDT

Currax Pharmaceuticals LLC today announced it has a Type C written response meeting with the U.S. Food and Drug Administration (“FDA”) regarding a New Drug Application for a Phase 3 program to evaluate the safety and efficacy of CX-101 (naltrexone HCl/bupropion HCl 8 mg/90 mg, extended-release tablets), for the indication of smoking cessation.

Apollo Medical Holdings, Inc. today announced that it will release financial results for the third quarter and nine months ended September 30, 2021, after the close of the stock market on Thursday, November 4, 2021.

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call at 8:00 a.m. ET Thursday, October 28, 2021 to report financial results for the quarter ended September 30, 2021 and discuss recent business highlights.

ReCode Therapeutics today announced the closing of an $80 million Series B financing round co-led by Pfizer Ventures and EcoR1 Capital.

Astria Therapeutics, Inc. today announced that it will share new preclinical results for STAR-0215 in a presentation titled “STAR-0215 Is a Long-Acting Monoclonal Antibody Plasma Kallikrein Inhibitor for the Potential Treatment of HAE” at the 2021 American College of Allergy, Asthma and Immunology Annual Scientific Meeting

Mapi Pharma Ltd. announced that it has entered new Middle Eastern markets with the signing of a distribution agreement granting Gaelan Medical Trade LLC, the healthcare arm of the Ghassan Aboud Group, an international conglomerate based in the United Arab Emirates, an exclusive right to market and distribute Mapi products in UAE.